免責聲明: 本站彙整 FDA、ClinicalTrials.gov、PubMed、SEC EDGAR 等官方公開資料,僅供一般參考,不構成醫療建議、診斷、治療建議或投資建議。

FDA 510(k)

CSF-3

K 號:K221260 · 2023-01-06

申請人Cardiacsense
決定日期2023-01-06
產品代碼DPS
諮詢委員會履歷
決定相當於

器材摘要

CSF-3 is the device name listed in this FDA 510(k) record. The listed applicant is Cardiacsense. It received FDA 510(k) clearance on 2023-01-06 under 510(k) number K221260. The device is classified under product code DPS. It was reviewed by the CV advisory panel. FDA Decision: Substantially Equivalent.

常見問題

What is the CSF-3?

CSF-3 is a medical device that received FDA 510(k) clearance on 2023-01-06. The listed applicant is Cardiacsense. The 510(k) number is K221260.

When did CSF-3 receive FDA 510(k) clearance?

CSF-3 received FDA 510(k) clearance on 2023-01-06, under 510(k) number K221260.

Who is the listed applicant for CSF-3?

The FDA 510(k) record lists Cardiacsense as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for CSF-3?

The FDA product code for CSF-3 is DPS.

其他以 Cardiacsense 為申請人之記錄

相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係,請查閱連結的官方來源。

相關器械(代碼:DPS)

相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係,請查閱連結的官方來源。

官方來源

在 FDA 資料庫中查看 →

資料來源為 FDA Open API。如需最新且權威的資訊,請始終參閱官方記錄。

↑